臺北醫學大學附設醫院

Medicine & Life Sciences

1. Taiwan 100%
2. Neoplasms 35%
3. Population 34%
4. Cohort Studies 29%
5. Therapeutics 26%
6. Confidence Intervals 25%
7. Meta-Analysis 24%
8. Stroke 24%
9. Odds Ratio 21%
10. Apoptosis 21%
11. Mortality 18%
12. Systematic Reviews 17%
13. Wounds and Injuries 17%
14. Breast Neoplasms 16%
15. Hepatocellular Carcinoma 16%
16. Colorectal Neoplasms 15%
17. Neoplasm Metastasis 15%
18. Proteins 15%
19. Databases 15%
20. Randomized Controlled Trials 14%
21. Inflammation 14%
22. Lung 13%
23. Bipolar Disorder 13%
24. In Vitro Techniques 13%
25. Serum 13%
26. Genes 13%
27. National Health Programs 12%
28. Chronic Renal Insufficiency 12%
29. Retrospective Studies 12%
30. Growth 11%
31. Kidney 11%
32. Incidence 11%
33. Survival 11%
34. Down-Regulation 11%
35. Biomarkers 10%
36. Bone and Bones 10%
37. Case-Control Studies 10%
38. Traumatic Brain Injury 10%
39. Logistic Models 10%
40. Renal Dialysis 9%
41. Carcinoma 9%
42. Lipopolysaccharides 9%
43. Child 9%
44. Pharmaceutical Preparations 9%
45. Prostatic Neoplasms 9%
46. Oxidative Stress 9%
47. Mesenchymal Stem Cells 9%
48. Anti-Inflammatory Agents 9%
49. Macrophages 9%
50. Liver 9%
51. Hyperoxia 9%
52. Gene Expression 9%
53. Blood Platelets 9%
54. Radiotherapy 8%
55. Lung Neoplasms 8%
56. Arsenic 8%
57. Up-Regulation 8%
58. Machine Learning 8%
59. Sleep 8%
60. Non-Small Cell Lung Carcinoma 8%
61. Cell Movement 8%
62. Recurrence 8%
63. Obesity 8%
64. Reactive Oxygen Species 8%
65. Hypertension 8%
66. Drug Therapy 8%
67. Colonic Neoplasms 8%
68. Pregnancy 8%
69. Autophagy 8%
70. Messenger RNA 8%
71. Cell Proliferation 8%
72. Fibrosis 7%
73. Comorbidity 7%
74. Stem Cells 7%
75. Mutation 7%
76. Parkinson Disease 7%
77. ErbB Receptors 7%
78. Phosphorylation 7%
79. Control Groups 7%
80. Cell Line 7%
81. Glioblastoma 7%
82. Datasets 7%
83. Cross-Sectional Studies 7%
84. Robotics 7%
85. Sepsis 7%
86. Propensity Score 7%
87. Brain 7%
88. Blood Pressure 7%
89. Endothelial Cells 7%
90. Pain 7%
91. MicroRNAs 7%
92. Antioxidants 7%
93. Depression 7%
94. Squamous Cell Carcinoma 7%
95. Quality of Life 7%
96. Glucose 7%
97. Catenins 7%
98. Safety 7%
99. Myocardial Infarction 7%
100. Equipment and Supplies 7%